Baird analyst Ben Kallo downgrades Embark Technology (NASDAQ:EMBK) from Outperform to Neutral and lowers the price target from $15 to $3.
BMO Capital Maintains Outperform on Bath & Body Works, Lowers Price Target to $45
BMO Capital analyst Simeon Siegel maintains Bath & Body Works (NYSE:BBWI) with a Outperform and lowers the price target from $65 to $45.